What they were paid
Clover Health Investments Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $67,500 | $206,096 | $0 | $0 | $273,596 |
| FY2024 | $69,384 | $190,329 | $0 | $0 | $259,713 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Clover Health Investments, Corp. DEF 14A filed April 28, 2026, accession 0001801170-26-000102, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Clover Health Investments pays directors a $50,000 cash retainer and $200,000 in RSUs.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance · Clinical
The rest of the Clover Health Investments board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Toy | Director | $0 |
| Anna U. Loengard | Independent Director | $278,596 |
| Demetrios L. Kouzoukas | Lead Independent Director | $301,096 |
| Thomas L. Tran | Independent Director | $275,179 |
| Vivek Garipalli | Chair of the Board | $0 |
| William G. Robinson, Jr | Independent Director | $286,096 |
The full Clover Health Investments compensation record
free company briefThis page is one director within Clover Health Investments's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat